Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 3 (gastrula)
Damuth DL et al. (2024)
|
Xla Wt + Xla.sox21.L
NF11-11.5 (RT-PCR)
|
|
|
|
Fig. 3 (neurula)
Damuth DL et al. (2024)
|
Xla Wt + Xla.sox21.S
NF15 (RT-PCR)
|
|
|
|
Fig. 5 FG
Devotta A et al. (2023)
|
Xla wt + A71915 (npr1 antagonist)
NF15 (in situ hybridization)
|
|
|
|
Fig 2 FG
Devotta A et al. (2023)
|
Xla wt + AP-811 (npr3 antagonist)
NF15 (in situ hybridization)
|
|
|
|
Fig 6 Ar1 B
Devotta A et al. (2023)
|
Xla Wt + nppa MO
NF15 (in situ hybridization)
|
|
|
|
Fig 6 A:r3 BDE
Devotta A et al. (2023)
|
Xla Wt + nppc MO
NF15 (in situ hybridization)
|
|
|
|
Fig. 5 B:c2r1 CD
Devotta A et al. (2023)
|
Xla Wt + npr1 MO
NF15 (in situ hybridization)
|
|
|
|
Fig. 2 CD
Devotta A et al. (2023)
|
Xla Wt + npr3 MO
NF15 (in situ hybridization)
|
|
|
|
Fig. 4 AB
Devotta A et al. (2023)
|
Xla Wt + npr3 MO
NF15 (in situ hybridization)
|
|
|
|
Fig. 3 a bottom row
Ihewulezi C and Saint-Jeannet JP (2021)
|
Xla Wt + hmgn1 MO
NF15 (in situ hybridization)
|
|
|